Are patients with lung cystic fibrosis at increased risk of severe and fatal COVID-19? Interleukin 6 as a predictor of COVID-19 outcomes Reply

被引：0
|
作者：
Kosmaczewska, Agata [1 ]
Frydecka, Irena [1 ]
机构：
[1] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Ul R Weigla 12, PL-53114 Wroclaw, Poland
来源：
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | 2020年 / 130卷 / 10期
关键词：
D O I：
10.20452/pamw.15660
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：920 / 921
页数：2
相关论文
共 50 条
  • [21] Lung transplantation for patients with severe COVID-19
    Bharat, Ankit
    Querrey, Melissa
    Markov, Nikolay S.
    Kim, Samuel
    Kurihara, Chitaru
    Garza-Castillon, Rafael
    Manerikar, Adwaiy
    Shilatifard, Ali
    Tomic, Rade
    Politanska, Yuliya
    Abdala-Valencia, Hiam
    Yeldandi, Anjana, V
    Lomasney, Jon W.
    Misharin, Alexander, V
    Budinger, G. R. Scott
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (574)
  • [22] Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19
    Wongvibulsin, Shannon
    Garibaldi, Brian T.
    Antar, Annukka A. R.
    Wen, Jiyang
    Wang, Mei-Cheng
    Gupta, Amita
    Bollinger, Robert
    Xu, Yanxun
    Wang, Kunbo
    Betz, Joshua F.
    Muschelli, John
    Bandeen-Roche, Karen
    Zeger, Scott L.
    Robinson, Matthew L.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (06) : 777 - +
  • [23] Severe COVID-19 outcomes in patients with psoriasis
    Lima, X. T.
    Cueva, M. A.
    Lopes, E. M.
    Alora, M. B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (12) : E776 - E778
  • [24] Cardiac Fibrosis Is a Risk Factor for Severe COVID-19
    Mustroph, Julian
    Hupf, Julian
    Baier, Maria J.
    Evert, Katja
    Brochhausen, Christoph
    Broeker, Katharina
    Meindl, Christine
    Seither, Benedikt
    Jungbauer, Carsten
    Evert, Matthias
    Maier, Lars S.
    Wagner, Stefan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [25] COVID-19: Rare variants increase the risk of severe COVID-19
    van de Veerdonk, Frank L.
    Netea, Mihai G.
    ELIFE, 2021, 10
  • [26] Interleukin 6 Antagonists in Severe COVID-19 Disease: Cardiovascular and Respiratory Outcomes
    Khan, Shahzad
    PROTEIN AND PEPTIDE LETTERS, 2024, 31 (03): : 178 - 191
  • [27] Ethnic disparities in COVID-19: increased risk of infection or severe disease? reply
    Mathur, Rohini
    Rentsch, Christopher T.
    Morton, Caroline E.
    Eggo, Rosalind M.
    Bhaskaran, Krishnan
    Tomlinsonn, Laurie
    Smeeth, Liam
    Goldacre, Ben
    LANCET, 2021, 398 (10298): : 390 - 390
  • [28] Risk of COVID-19 in Patients With Cancer Reply
    Chua, Melvin L. K.
    Yu, Jing
    Xie, Conghua
    JAMA ONCOLOGY, 2020, 6 (09) : 1472 - 1473
  • [29] Asthma as a predictor of more severe outcomes in COVID-19 infection
    Eggert, Lauren
    Cao, Shu
    He, Ziyuan
    Dhondalay, Gopal Krishna
    Jiang, Shirley
    Collins, William
    Sindher, Sayantani
    Nadeau, Kari
    Sharon Chinthrajah, R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB44 - AB44
  • [30] Patients with low ALT levels are at increased risk for severe COVID-19
    Genzel, Dor
    Katz, Lior H.
    Safadi, Rifaat
    Rozenberg, Aliza
    Milgrom, Yael
    Jacobs, Jeremy M.
    Shafrir, Asher
    FRONTIERS IN MEDICINE, 2023, 10
12345